ADvantage Therapeutics Inc.

0 followers


ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease. The company is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter.

Industries

Headquarters

Employees

Links

Org chart

Jeffrey Madden
Co-founder And CEO

Jeffrey Madden

Collapse
David Buchsbaum
Chief Financial Officer
Frank Mattner
Präsident und CSO